Older patients, females, and those with comorbidities were more likely to be on multiple medications.
Your search for apixaban returned 3 results
Researchers conducted a post hoc analysis of the ARISTOTLE trial which included patients with atrial fibrillation (AF) and a risk of stroke treated with either apixaban or warfarin for the prevention of stroke/ systemic embolism.
Reversal of anticoagulant activity of apixaban and rivaroxaban seen in older healthy participants